Is het Eurofins Scientific dividend veilig?
Eurofins Scientific verhoogt het dividend al 12 jaar.
Binnen de laatste 10 jaar heeft Eurofins Scientific deze met jaarlijks 25,893 % verhoogd verhoogd.
Op 5-jaarsbasis is de uitkering met steeg toegenomen met 33,032 %.
De analisten verwachten voor het lopende boekjaar een Dividendengroei van 4,358%.
Eurofins Scientific Aktienanalyse
Wat doet Eurofins Scientific?
Eurofins Scientific SE is a leading group of laboratories specializing in providing testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. The company was founded in 1987 by Dr. Gilles Martin and is headquartered in Luxembourg. It has since become one of the largest laboratory service providers worldwide.
Eurofins' business model is based on a wide range of analytical services that enable customers to monitor product quality, process safety, and regulatory compliance. Eurofins offers a comprehensive range of tests, including food and feed testing, residue analysis, hygiene and contamination analysis, environmental analysis, and genetic testing.
The group operates more than 800 laboratories in 47 countries and employs more than 50,000 people. Eurofins has a strong presence in Europe, North America, and the Asia-Pacific region, and is active in various industries such as agriculture and food, environment and pharmaceuticals, as well as clinical diagnostics and forensics.
The different divisions of Eurofins are tailored to the specific needs of its customers. For example, the "Food Testing" division offers a wide range of tests to ensure that food is safe and healthy. Thanks to these tests, manufacturers can ensure that their products comply with legal requirements and meet customer needs.
Another division of Eurofins is "Environment Testing," which offers tests and analyses for a variety of environmental samples. These enable companies to monitor compliance with environmental regulations, identify environmental issues, and improve their environmental footprint.
Eurofins' Biopharma division offers a variety of testing services for the biopharmaceutical industry, including clearance studies, cleaning validation, particle measurements, and DNA sequencing.
In the field of clinical diagnostics, Eurofins provides laboratory services to improve diagnoses and treatments. These include genetic testing, oncology tests, prenatal diagnostics, and infectious diseases.
Another important business area for Eurofins is forensics, which benefits from the latest developments in DNA analysis as well as analysis methods for detecting drugs, alcohol, and toxic substances. The services provided by Eurofins include forensic wildlife investigations and the identification of human and animal species based on DNA samples.
In addition to the aforementioned business areas, Eurofins also offers a wide range of services such as consulting, audits, and training to help improve its customers' performance and help them achieve their business goals.
In conclusion, Eurofins Scientific SE is a leading provider of testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. With its specialized services, the company enables its customers to monitor product quality, process safety, and regulatory compliance. Eurofins' various divisions offer tests and analyses for a variety of industries, contributing to improving its customers' businesses. Eurofins Scientific is een van de populairste bedrijven op Eulerpool.com.Aandelen spaarplannen bieden een aantrekkelijke mogelijkheid voor beleggers om op de lange termijn vermogen op te bouwen. Een van de belangrijkste voordelen is het zogenaamde cost-average-effect: door regelmatig een vast bedrag in aandelen of aandelenfondsen te investeren, koopt men automatisch meer aandelen wanneer de prijzen laag zijn, en minder wanneer ze hoog zijn. Dit kan leiden tot een voordeligere gemiddelde prijs per aandeel over de tijd. Bovendien maken aandelen spaarplannen het ook voor kleine beleggers mogelijk om toegang te krijgen tot dure aandelen, aangezien ze al met kleine bedragen kunnen deelnemen. De regelmatige investering bevordert ook een gedisciplineerde beleggingsstrategie en helpt emotionele beslissingen, zoals impulsief kopen of verkopen, te voorkomen. Daarnaast profiteren beleggers van de potentiële waardestijging van de aandelen en van dividenduitkeringen die herinvesteerd kunnen worden, wat het effect van samengestelde interest versterkt en daarmee de groei van het geïnvesteerde kapitaal.